Literature DB >> 8262561

High expression of NK-1.1 antigen is induced by infection with murine AIDS virus.

M Makino1, D F Winkler, J Wunderlich, J W Hartley, H C Morse, K L Holmes.   

Abstract

Spleen cells from mice infected with LP-BM5 MuLV, a causative agent of murine acquired immunodeficiency syndrome (MAIDS), were tested for frequency of NK-1.1+ cells and natural killer (NK) activity. During the first 3 weeks following infection, NK activity was well conserved, but by 9-12 weeks post-infection (p.i.), killer activity was depressed; however, the frequency of NK-1.1+ cells increased within 4 weeks of infection and remained elevated thereafter, even following the decline in functional killing activity. Since the absolute number of NK-1.1+ cells increased after infection, the ability of each NK-1.1+ cell to kill the targets seems drastically impaired. Extraordinary expansion of NK-1.1-positive cells was induced by infection with LP-BM5-defective virus (BM5def), a crucial element for MAIDS induction, but not with a helper non-pathogenic virus. With advance of MAIDS the NK-1.1 antigen (Ag) was preferentially expressed on B220+ and Thy-1+ cells, in contrast to CD4+ and CD8+ cells, and among activated large cells a higher proportion was NK-1.1+ than NK-1.1-. Mice with graft-versus-host disease (GVHD) due to class II major histocompatibility complex (MHC) Ag disparity showed a high frequency of NK-1.1 expression in association with other phenotypic alterations, very similar to those seen in mice with MAIDS. In contrast, B6-lpr/lpr mice developed similar activation of B cells but did not exhibit enhanced expression of the NK-1.1 marker. Thus, enhanced expression of the NK-1.1 Ag might be associated with chronic activation of lymphocytes through a common but not universal pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262561      PMCID: PMC1422179     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Establishment of monoclonal anti-Nk-1.1 antibody.

Authors:  G C Koo; J R Peppard
Journal:  Hybridoma       Date:  1984

2.  Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses.

Authors:  R M Buller; R A Yetter; T N Fredrickson; H C Morse
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains.

Authors:  J W Hartley; T N Fredrickson; R A Yetter; M Makino; H C Morse
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Ontogeny of Nk-1+ natural killer cells. I. Promotion of Nk-1+ cells in fetal, baby, and old mice.

Authors:  G C Koo; J R Peppard; A Hatzfeld
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

5.  Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.

Authors:  J Hackett; M Tutt; M Lipscomb; M Bennett; G Koo; V Kumar
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

6.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Broadly reactive murine cytotoxic cells induced in vitro under syngeneic conditions.

Authors:  N Dorfman; D Winkler; R C Burton; N Kossayda; P Sabia; J Wunderlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS).

Authors:  R A Yetter; R M Buller; J S Lee; K L Elkins; D E Mosier; T N Fredrickson; H C Morse
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

9.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

10.  Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.

Authors:  A G Rolink; S T Pals; E Gleichmann
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  4 in total

1.  Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.

Authors:  N A Giese; R T Gazzinelli; J K Actor; R A Morawetz; M Sarzotti; H C Morse
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 2.  Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  H C Morse; N Giese; R Morawetz; Y Tang; R Gazzinelli; W K Kim; S Chattopadhyay; J W Hartley
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Oral carriage of Candida albicans in murine AIDS.

Authors:  N Deslauriers; L Côté; S Montplaisir; L de Repentigny
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 4.  SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis.

Authors:  Christine I Alston; Richard D Dix
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.